These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2134708)

  • 1. The thermal stability of yellow fever vaccines.
    Ishak R; Howard CR
    Mem Inst Oswaldo Cruz; 1990; 85(3):339-45. PubMed ID: 2134708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability-related studies on 17D yellow fever vaccine.
    Perraut R; Girault G; Moreau JP
    Microbes Infect; 2000 Jan; 2(1):33-8. PubMed ID: 10717538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of 17D yellow fever virus vaccine using different stabilizers.
    Adebayo AA; Sim-Brandenburg JW; Emmel H; Olaleye DO; Niedrig M
    Biologicals; 1998 Dec; 26(4):309-16. PubMed ID: 10403034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the stability of 17D-204 yellow fever vaccine before and after stabilization.
    Sood DK; Aggarwal RK; Sharma SB; Sokhey J; Singh H
    Vaccine; 1993; 11(11):1124-8. PubMed ID: 8249431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The quality standardization of a national vaccine against yellow fever].
    Rasshchepkina MN; Levina VD; Vorob'eva MS; Kozlov VG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):47-50. PubMed ID: 2251891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid test for measuring the infectivity of Yellow Fever vaccine.
    Sood DK; Aggarwal RK; Kumar S; Sokhey J
    Vaccine; 1995 Apr; 13(5):427-8. PubMed ID: 7639009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on yellow fever vaccine. II--Stability of the reconstituted product.
    Lopes Ode S; Guimarães SS; de Carvalho R
    J Biol Stand; 1988 Apr; 16(2):71-6. PubMed ID: 3372544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine.
    Georges AJ; Tible F; Meunier DM; Gonzalez JP; Beraud AM; Sissoko-Dybdahl NR; Abdul-Wahid S; Fritzell B; Girard M; Georges-Courbot MC
    Vaccine; 1985 Sep; 3(3):313-5. PubMed ID: 4060841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983].
    Saluzzo JF; Some L; Baudon D; Girault G; Lhuillier M; Kambire PA; Roux JF; Digoutte JP
    Bull Soc Pathol Exot Filiales; 1985; 78(4):536-40. PubMed ID: 4075474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thermal stability of a stabilized 17D yellow fever virus vaccine.
    Burfoot C; Young PA; Finter NB
    J Biol Stand; 1977; 5(3):173-9. PubMed ID: 893463
    [No Abstract]   [Full Text] [Related]  

  • 13. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
    Ferguson M; Heath A
    Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice.
    Yang H; Yang H; Li Z; Liu L; Wang W; He T; Fan F; Sun Y; Liu J; Li Y; Zeng X
    Vaccine; 2018 Apr; 36(18):2450-2455. PubMed ID: 29580643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.
    Poland JD; Calisher CH; Monath TP; Downs WG; Murphy K
    Bull World Health Organ; 1981; 59(6):895-900. PubMed ID: 6978196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neurovirulence of different strains of yellow fever virus in mice.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():631-7. PubMed ID: 3958694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay.
    Barry M; Patterson JE; Tirrell S; Cullen MR; Shope RE
    Am J Trop Med Hyg; 1991 Jan; 44(1):79-82. PubMed ID: 1996743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.